Dietary palmitic acid promotes tumor growth and epithelial-mesenchymal transformation in prostate cancer

F Huang, B Sun, X Wang, X Jian, Q Du, J Chen - 2021 - researchsquare.com
Background High-fat diet (HFD) is a major risk factor for prostate cancer (PCA). Palmitic acid
(PA) is the main constituent of HFD, and the main end product of fatty acid synthase (FASN) …

[HTML][HTML] Современные подходы к таргетной биопсии предстательной железы

СВ Попов, ИН Орлов, СМ Малевич, ИВ Сушина… - …, 2021 - cyberleninka.ru
Рак предстательной железы (РПЖ) занимает 2-е место в структуре онкологической
заболеваемости мужчин и 5-е место среди причин смерти населения в мире. Согласно …

Структурная модель формирования пакетов клинико-диагностических тестов при организации персонализированной медицинской помощи пациентам со …

ДА Андреев, АА Завьялов - Российский медицинский журнал, 2021 - elibrary.ru
Актуальность. Рак предстательной железы представляет собой серьезную социально-
экономическую проблему, занимает второе место среди наиболее часто …

[PDF][PDF] EXPERIÊNCIA DE UM SERVIÇO PÚBLICO DE UROLOGIA EM SAÚDE DO HOMEM. REPERCUSSÃO EPIDEMIOLÓGICA DO RASTREIO DO CÂNCER DE …

WW Laranja - 2022 - repositorio.unicamp.br
Objetivo: Avaliar o perfil epidemiológico dos pacientes durante uma década, em relação a
avaliação prostática em um serviço de saúde pública e observar se esse serviço pode ser …

Focal therapy for prostate cancer: now and future

HAN Bangmin, C Shaoan - J Clin Urol, 2024 - lcmwen.whuhzzs.com
Focal therapy for prostate cancer aims to selectively ablate tumor while protecting important
anatomical structures such as the neurovascular bundle, sphincter, and urethra at the same …

Research progress of robot and imaging techniques in prostate biopsy

LI Youwen, Z Tao - J Clin Urol, 2023 - lcmwen.whuhzzs.com
Prostate cancer is the most common malignancy of the male urinary system. The tumor is
highly aggressive, and most prostate cancer patients have progressed to advanced stage …

Differential genetic events in the two main pathways of prostate carcinogenesis: Molecular, pathological and clinical analysis of crucial genetic alterations in ETS …

L Segalés Tañà - 2022 - repositori.upf.edu
Two main carcinogenic pathways have been identified in prostate cancer (PrCa): the ETS
fusion-positive and the ETS fusion-negative pathways. The aim of this project has been to …

Caracterização do Estroma Reativo do Câncer de Próstata em função da Morfologia Acinar e da assinatura do colágeno por imunohistoquímica e à microscopia por …

EP Júnior - 2022 - repositorio.ufmg.br
INTRODUÇÃO: O carcinoma de próstata (CaP) é tumor heterogêneo de alta incidência e
evolução lenta. O prognóstico baseia-se no grau histológico dado pelo Sistema Gleason …

Quicker and digital: the way on protein biomarkers?

GA Calin - Blood, The Journal of the American Society of …, 2021 - ashpublications.org
For most chronic diseases, biomarker assays should be highly reproducible, with high
sensitivity and specificity. The tradeoff for these advantages is usually the time of execution …

Current approaches to targeted prostate biopsy

SV Popov, IN Orlov, SM Malevich, IV Sushina… - Urologiia, 2021 - pediatria.orscience.ru
Currently, prostate cancer (PCa) is the second most common malignancy in men after lung
cancer and the fifth leading cause of death worldwide. According to world and national …